Last updated on January 2020

A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Erythroblastosis Fetalis | Early Onset Severe Hemolytic Disease of the Fetus and Newborn (EOS-HDFN)
  • Age: Between 18 - 100 Years
  • Gender: Female

Pregnant female participants must be 18 years of age with an estimated Gestational Age of 8 weeks; not currently pregnant with multiples (twins or more); and no other clinically relevant abnormalities currently or in their history that the Investigator would deem them ineligible to participate.

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.